By Aditya Raghunath
Investing.com -- Subscribers who held on to their shares of Nureca Ltd (NS:NURE), the healthcare and wellness company, that made its debut on the stock markets on February 25 must be very pleased with their decision.
The stock, which had an issue price of Rs 400, is trading at Rs 1,005 at the time of this report. That’s a gain of over 151% in less than two months. The company’s products like oximeters, thermometers, blood pressure monitors, and electric massagers are seeing a lot of demand in the market today.
Its mother and child products under the brand Trumom have also seen good traction. Dr. Trust, its flagship brand, had products that enable people to address chronic ailments. Dr. Physio, the second biggest brand in the Nureca stable, has products for orthopedics.
The company also focuses heavily on the lifestyle and wellness range whose demand is expected to grow exponentially in India. According to a FICCI report, this space is valued at Rs 49,000 crore. A report in the Financial Express said, “According to Numb Research – an Indian market research firm – India’s 443 million millennials spend an average of Rs 4,000 per month on health and wellness services and products.”
It looks like Nureca is well placed in this space.